Close
The page header's logo
Help
Login
Staff Login
Register
FR
0
Selected 
Invert selection
Deselect all
Deselect all
 Add to Cart
 Click here to refresh results
 Click here to refresh results
Go to Login page
 Hide details
doctype icon
Conceptually similar
Quebec reports first blood clot death in woman who received AstraZeneca vaccine
play button
CP122404571 | Quebec reports first blood clot death in woman who received AstraZeneca vaccine 
N.S. pauses use of AstraZeneca vaccine
play button
CP123262421 | N.S. pauses use of AstraZeneca vaccine 
AstraZeneca vaccine to remain authorized in Canada
play button
CP121635062 | AstraZeneca vaccine to remain authorized in Canada 
AstraZeneca blood clot risk remains low: Tam
play button
CP122017117 | AstraZeneca blood clot risk remains low: Tam 
Nova Scotia to expand use of Oxford-AstraZeneca vaccine to those 55-64
play button
CP120960271 | Nova Scotia to expand use of Oxford-AstraZeneca vaccine to those 55-64 
N.S. to start administering AstraZeneca vaccines
play button
CP119781421 | N.S. to start administering AstraZeneca vaccines 
B.C. records first case of rare blood clot related to vaccine
play button
CP122904771 | B.C. records first case of rare blood clot related to vaccine 
AstraZeneca vaccine's benefits vastly outweigh risks: Sharma
play button
CP120476771 | AstraZeneca vaccine's benefits vastly outweigh risks: Sharma 
Ontario to resume AstraZeneca shots for COVID-19 as second dose
play button
CP123774871 | Ontario to resume AstraZeneca shots for COVID-19 as second dose 
AstraZeneca vaccine authorized in Canada
play button
CP118971421 | AstraZeneca vaccine authorized in Canada 
Action button
Placeline/People
City Vaughan
Country Canada

New Brunswick reports blood clot death in connection with Oxford-AstraZeneca vaccine

New Brunswick health officials are reporting the province's first death of someone who developed a blood clot after receiving the Oxford-AstraZeneca vaccine. Chief medical officer of health Dr. Jennifer Russell says the person in their 60s received the vaccine in mid-April and developed symptoms a week later, was admitted to hospital, and died two days later. 
Actions
 Add to collection
 Add to cart
Information
Source name: 
The Canadian Press
Unique identifier: CP122830710 
Legacy Identifier: n_COVID-NB20210505T1507 
Type: Video 
Duration: 2m20s 
Dimensions: 1920px × 1080px     157.02 MB 
Usage rights: FOR ONE TIME USE ONLY. NO STORAGE FOR FUTURE USE. 
Create Date: 5/5/2021 3:07:00 PM 
Display aspect ratio: 16:9 
Tags
blood clot
COVID-19
death
N.B.
Oxford-AstraZeneca
Vaccination
vaccine